PCSK9 Inhibitors - Alirocumab and Evolucumab- Key Insights on Differentiation in a Generic Market
May 1, 2016, 00:00
10.1016/j.jval.2016.03.152
https://www.valueinhealthjournal.com/article/S1098-3015(16)00220-5/fulltext
Title :
PCSK9 Inhibitors - Alirocumab and Evolucumab- Key Insights on Differentiation in a Generic Market
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)00220-5&doi=10.1016/j.jval.2016.03.152
First page :
A57
Section Title :
Cardiovascular Disorders - Health Care Use & Policy Studies
Open access? :
No
Section Order :
1500